Form 8-K - Current report:
SEC Accession No. 0001493152-22-017526
Filing Date
2022-06-22
Accepted
2022-06-22 17:15:12
Documents
12
Period of Report
2022-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41433
  Complete submission text file 0001493152-22-017526.txt   214197

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avte-20220621.xsd EX-101.SCH 2965
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avte-20220621_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avte-20220621_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3612
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 221032889
SIC: 2834 Pharmaceutical Preparations